Gangolli Julian S
CIK: 0001532023
Director
Primary company: ALLERGAN INC (AGN)
Gangolli Julian S is a corporate insider at ALLERGAN INC (AGN) filing SEC Form 4 transactions. 121 transactions across 5 companies, totaling $0 in purchases and $27,378,160 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 471 | - | - | 471 | 9/14/2026 Filed: 9/14/2026 | Filing → | |
| Award | 1,187 | $340.03 | $404K | 1,187 | 9/14/2026 Filed: 9/14/2026 | Filing → | |
| Award | 286,734 | - | - | 286,734 | 10/1/2025 Filed: 10/3/2025 | Filing → | |
| Award | 5,000 | - | - | 5,000 | 6/30/2025 Filed: 6/30/2025 | Filing → | |
Revance Therapeutics, Inc. RVNC | Disposition | 15,000 | - | - | 0 | 2/6/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | U | 30,106 | $3.65 | $110K | 15,000 | 2/4/2025 Filed: 2/6/2025 | Filing → |
| Award | 71,169 | - | - | 71,169 | 10/1/2024 Filed: 10/3/2024 | Filing → | |
| Award | 56,636 | - | - | 56,636 | 10/1/2024 Filed: 10/3/2024 | Filing → | |
| Award | 5,000 | - | - | 5,000 | 6/30/2024 Filed: 7/1/2024 | Filing → | |
| Exercise | 20,000 | - | - | 0 | 5/20/2024 Filed: 5/22/2024 | Filing → | |
| Sale | 1,980 | $165.76 | $328K | 0 | 5/20/2024 Filed: 5/22/2024 | Filing → | |
| Sale | 7,090 | $164.34 | $1.17M | 1,980 | 5/20/2024 Filed: 5/22/2024 | Filing → | |
| Sale | 10,930 | $163.71 | $1.79M | 9,070 | 5/20/2024 Filed: 5/22/2024 | Filing → | |
| Exercise | 20,000 | $22.75 | $455K | 20,000 | 5/20/2024 Filed: 5/22/2024 | Filing → | |
Revance Therapeutics, Inc. RVNC | Award | 23,458 | - | - | 23,458 | 5/1/2024 Filed: 5/3/2024 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 15,000 | - | - | 45,106 | 5/1/2024 Filed: 5/3/2024 | Filing → |
| Award | 94,441 | - | - | 94,441 | 3/7/2024 Filed: 3/8/2024 | Filing → | |
| Award | 370,282 | $0.00 | $0 | 370,282 | 10/4/2023 Filed: 10/6/2023 | Filing → | |
| Award | 6,800 | $0.00 | $0 | 6,800 | 6/30/2023 Filed: 7/3/2023 | Filing → | |
Revance Therapeutics, Inc. RVNC | Award | 5,915 | $0.00 | $0 | 5,915 | 5/3/2023 Filed: 5/5/2023 | Filing → |
Type
Award
Shares
471
Price
-
Value
-
Type
Award
Shares
1,187
Price
$340.03
Value
$404K
Type
Award
Shares
286,734
Price
-
Value
-
Type
Award
Shares
5,000
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Disposition
Shares
15,000
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
U
Shares
30,106
Price
$3.65
Value
$110K
Type
Award
Shares
71,169
Price
-
Value
-
Type
Award
Shares
56,636
Price
-
Value
-
Type
Award
Shares
5,000
Price
-
Value
-
Type
Exercise
Shares
20,000
Price
-
Value
-
Type
Sale
Shares
1,980
Price
$165.76
Value
$328K
Type
Sale
Shares
7,090
Price
$164.34
Value
$1.17M
Type
Sale
Shares
10,930
Price
$163.71
Value
$1.79M
Type
Exercise
Shares
20,000
Price
$22.75
Value
$455K
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
23,458
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
15,000
Price
-
Value
-
Type
Award
Shares
94,441
Price
-
Value
-
Type
Award
Shares
370,282
Price
$0.00
Value
$0
Type
Award
Shares
6,800
Price
$0.00
Value
$0
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
5,915
Price
$0.00
Value
$0
AI Agent
Try asking...